Table 2 Annual fibrotic change in patients with different fibrotic stages.

From: Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals

 

All patients (n = 156)

interval <1.5 year (n = 70)

interval >1.5 year (n = 86)

P value

All patients

0.16 + 0.79

0.13 + 0.99

0.19 + 0.57

0.58

F01 (n = 70)

−0.10 + 0.58a

−0.18 + 0.74 (n = 30)

−0.04 + 0.42 (n = 40)

0.65

F2 (n = 44)

0.14 + 0.87a

0.06 + 0.99(n = 27)

0.25 + 0.63 (n = 17)

0.49

F3 (n = 26)

0.69 + 0.97a

1.22 + 1.31 (n = 8)

0.46 + 0.70 (n = 18)

0.11

F4 (n = 16)

0.51 + 0.49a

0.60 + 0.61 (n = 5)

0.48 + 0.46 (n = 11)

0.58

  1. Note: F: fibrosis. Interval: interval between paired biopsy. aTrend P < 0.001.